Fresh Tracks Therapeutics Competitors and Similar CompaniesClear all

Fresh Tracks Therapeutics's competitors and similar companies include Pharming Group and Alexion Pharmaceuticals.
Fresh Tracks Therapeutics
Fresh Tracks Therapeutics
Fresh Tracks Therapeutics (formerly known as Brickell Biotech) is a clinical-stage pharmaceutical company focused on the development of innovative and differentiated therapeutics for the treatment of skin diseases.
Pharming Group
Pharming Group
Pharming Group is a biopharmaceutical company developing protein replacement therapies and precision medicines for the treatment of rare diseases.
Alexion Pharmaceuticals
Alexion Pharmaceuticals
Alexion (also known as Alexion, AstraZeneca Rare Disease) is a biopharmaceutical company engaged in therapies for rare diseases.
Founding Date
Founding Date
2009
Founding Date
1988
Founding Date
1992
Type
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Boulder, US HQ
Carmel, US
Locations
Leiden, NL HQ
Leiden, NL
Locations
Boston, US HQ
Frenchs Forest, AU
Wien, AT
Elsene, BE
São Paulo, BR
Vaughan, CA
Shanghai, CN
see more
Employees
Employees
1338% decrease
Employees
404
Employees
10,6006% increase
Valuation ($)
Valuation ($)
4.3 m
Valuation ($)
590.3 m
Valuation ($)
40.3 b

Financial

Revenue (est.)
Revenue (est.)
$8m (FY, 2023)
Revenue (est.)
$376.1m (FY, 2025)
Revenue (est.)
$6.1b (FY, 2020)
Cost of goods
Cost of goods
N/A
Cost of goods
$41.6m (FY, 2025)
Cost of goods
$553.5m (FY, 2020)
Gross profit
Gross profit
N/A
Gross profit
$341m (FY, 2025)
Gross profit
$5.5b (FY, 2020)
Net income
Net income
($5.7m) (FY, 2023)
Net income
$2.5m (FY, 2025)
Net income
$603.4m (FY, 2020)
For sources of this data, please see the company profile

View Company Profiles

Pharming Group
HQ
Leiden, NL
Employees
404

Pharming Group is a biopharmaceutical company developing protein replacement therapies and precision medicines for the treatment of rare diseases.

View company
Alexion Pharmaceuticals
HQ
Boston, US
Employees
10,600↑ 6% increase

Alexion (also known as Alexion, AstraZeneca Rare Disease) is a biopharmaceutical company engaged in therapies for rare diseases.

View company